Glucotrack plans FDA filing for glucose monitoring device in Q2

Go back to Glucotrack plans FDA filing for glucose monitoring device in Q2
(NASDAQ: GCTK) Delayed: 0.35 -0.01 (2.78%)
Previous Close $0.36    52 Week High
Open $0.36    52 Week Low
Day High $0.36    P/E N/A 
Day Low $0.34    EPS
Volume 295,382